Global Alternative Tobacco and Smoking Cessation Market Share & Size, Growth, Industry Trends | Emergen Research

The global alternative tobacco and smoking cessation market size was USD 26.30 Billion in 2022 and is expected to register a steady revenue CAGR of 9.4% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of respiratory lung diseases, such as chronic bronchitis and rising investments and funding towards production of such devices are key factors driving market revenue growth.

Alternative nicotine and tobacco products, such as Electronic Cigarettes (EC), smokeless tobacco, and Nicotine Replacement Therapy (NRT), are now being evaluated as tobacco harm reduction options due to their potential role in smoking reduction and smoking cessation. The development and innovation of alternative nicotine consumption products represent an important shift from a market formerly influenced by cigarettes. In addition, increasing use of vaping devices, oral nicotine delivery, and Heat-Not-Burn (HNB) or Heated Tobacco Products (HTPs) is another key factor driving revenue growth of the market. Newer tobacco product marketing incorporates messaging implying that these smokeless tobacco products aid in the decrease or cessation of cigarette consumption or that these should be used in smoke-free environments.

Although traditional cigarettes continue to be the most popular method of tobacco consumption, use of non-combustible tobacco and nicotine products have increased rapidly in the last fifteen years, and their use is expected to rise further in the coming years. Tobacco-based products, such as HTPs and nicotine-only products including vapor products (electronic cigarettes) and nicotine pouches, are examples of these goods. Innovative nicotine-based alternatives benefit the industry since these increase revenues through lower taxation, are not entirely covered by tobacco legislation, compensate smokers who quit smoking, and bring in new clients of tobacco and/or nicotine products.

Moreover, technological improvements in alternative tobacco products is also expected to drive market revenue growth during the forecast period. Modern oral nicotine solutions, including vaping, offer users a safer alternative to combustible cigarettes. Furthermore, tobacco-free nicotine pouches are gaining popularity since these resemble chewing tobacco and snus, but do not contain tobacco.

Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/2344

However, rising costs of such products as well as concerns regarding their safety profile are key factors, which could restrain market revenue growth. Some alternative nicotine products have harmful effects, such as concentrations of toxicants in liquids, used in e-cigarettes fluctuating and the quality control in e-cigarette manufacturing is speculative. A number of toxicants have been detected in e-cigarette vapors. A few health risks include toxicology of flavoring substances contained in liquids when inhaled, the formation of acetals (chemicals whose toxicological properties are unknown) and carbonyl compounds during the heating process, and presence of carcinogenic metals in the emissions. Furthermore, despite the reduction of some types of chemicals identified in emissions, early study has discovered the existence of certain carcinogenic or mutagenic elements in heated tobacco products, often in higher concentrations than in tobacco cigarette emissions.

 Market Drivers and Trends Alternative nicotine products, including electronic cigarettes (e-cigarettes), smokeless tobacco, and nicotine replacement therapies (NRTs), are gaining traction as potential tools for reducing or quitting smoking. The shift from traditional cigarettes to these innovative products is significant, driven by advancements in product technology and increased consumer demand for safer options. Modern products like vaping devices, heated tobacco products (HTPs), and nicotine pouches offer new ways for users to consume nicotine, leading to a change in market dynamics.

HTPs, which heat but do not burn tobacco, have become particularly popular, showing a substantial reduction in harmful tobacco components compared to traditional cigarettes. These products have also been marketed for their more socially acceptable use and lack of strong odors or visible emissions, making them appealing for public use where smoking is restricted.

The rise of online pharmacies is playing a major role in market growth. Consumers prefer purchasing alternative tobacco products online due to the variety of options, competitive pricing, and convenience of home delivery. The shift to e-commerce has led to significant sales growth, as more people buy both prescription and over-the-counter smoking cessation products from the comfort of their homes.

For More Details On this Report Click Here @ https://www.emergenresearch.com/industry-report/alternative-tobacco-and-smoking-cessation-market

Challenges Despite these positive trends, the market faces challenges. The safety and long-term health effects of some alternative products remain a concern. E-cigarette liquids can contain fluctuating toxicant levels, and studies have found carcinogenic substances in both e-cigarette vapor and HTP emissions. The manufacturing quality of e-cigarettes can also be inconsistent, leading to potential safety issues. These factors may slow market growth as consumers become more cautious.

Regional Insights North America held the largest share of the global market in 2022, driven by increased investments and strategic initiatives aimed at developing and marketing smokeless and alternative smoking products. For example, the U.S. Food and Drug Administration (FDA) approved 22nd Century Group Inc.'s VLN King and VLN Menthol King cigarettes as Modified Risk Tobacco Products (MRTPs) in December 2021, indicating a significant regulatory shift. These approvals support the availability of products that reduce exposure to nicotine and toxicants.

Key Market Segments The market is segmented by product type, including NRTs, smokeless tobacco, e-cigarettes, HTPs, and prescription medications. Among these, the online pharmacies segment led the market in 2022 due to the convenience and growth of e-commerce platforms.

The HTP segment is also expected to grow rapidly, supported by increasing consumer interest and the push for products marketed as safer alternatives to traditional cigarettes.

Recent Developments In June 2023, Imperial Brands announced the acquisition of nicotine pouches from TJP Labs to expand into the U.S. oral nicotine market. This acquisition will enable Imperial's subsidiary, ITG Brands, to launch a range of products designed to meet consumer preferences, with a planned product relaunch set for 2024.

Leading Companies

he global alternative tobacco and smoking cessation market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective alternative tobacco and smoking cessation solutions.

Some major companies included in the Alternative Tobacco and Smoking Cessation Market report are:

Pfizer Inc.
GSK plc.
NJOY
VMR Products, LLC
McNeil AB
Takeda Pharmaceutical Company Ltd.
Novartis AG
Johnson & Johnson
Imperial Brands PLC.
Perrigo Company plc.

To Customized Report Market: @ https://www.emergenresearch.com/request-for-customization/2344

Alternative Tobacco and Smoking Cessation Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented global alternative tobacco and smoking cessation market on the basis of product type, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2019-2032)
Nicotine Replacement Therapy (NRT)
NRT Gums
NRT Lozenges
NRT Inhalers
NRT Patches
NRT Nasal Spray
Smokeless Tobacco
Electronic Cigarettes (e-cigarettes)
Heated Tobacco Products (HTPs)
Prescription Medications
Others

End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.